• Home
  • Shanxi Zhendong Pharmaceutical Co,ltd.
16
Jun
2027
National Exhibition and Convention Center
16 Jun 2027 - 18 Jun 2027
stand 82J88
Book a meeting

Shanxi Zhendong Pharmaceutical Co,ltd.

About Shanxi Zhendong Pharmaceutical Co,ltd.

Listed company ,covers Chinese and Western pharmaceutical ,functional foods, home care, cultural tourism and agricultural development and operates 32 subsidiary companies and over 6,000 employees.

Read more Show less
Categories
more categories Show less

Meet us at

  • CPHI & PMEC China 2027

    CPHI & PMEC China 2027

    National Exhibition and Convention Center
    16 Jun 2027 - 18 Jun 2027
    stand 82J88
  • Country/Region:
    China
  • On CPHI since:
    2017
Contact info
  • 3558096034
  • Website
  • ZHENDONG SCIENCE PARK, GUANGMING SOUTH ROAD, CHANGZHI COUNTY, 047100, SHANXI PROVINCE, Beijing, China
Show contact info Hide contact info

Products from Shanxi Zhendong Pharmaceutical Co,ltd. (3)

  • Abiraterone acetate tablets

    Product Abiraterone acetate tablets

    Abiraterone works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.


    Abiraterone is used together with steroid medication (prednisone or methylprednisolone) to treat prostate cancer that has spread to o...
  • Bicalutamide capsules

    Product Bicalutamide capsules

    50mg daily: Combination with luteinizing hormone releasing hormone (LHRH) analogs or surgical orchiectomy for the treatment of advanced prostatic carcinoma.

    150mg daily: For the treatment of patients with locally advanced prostate cancer without distant metastasis, who are unsuitable or unwillin...
  • Enzalutamide Soft Capsules

    Product Enzalutamide Soft Capsules

    Suitable for metastatic resistance to prostate cancer (CRPC). After the failure of androgen deprivation of therapy (ADT), Enzalutamide can delay the progress of the disease by inhibiting the inhibitors of therogen receptor signaling pathway and improve the quality of life of patients.